Abstract
Background: Advances in the medicinal nanotechnology have given upward thrust to multifunctional efficient nanocarriers that can be engineered with tunable physico-chemical traits to deliver one or extra healing agent(s) appropriately and selectively to the most cancers cells, focusing on intracellular organellespecific drug delivery.
Objective: Large pores of mesoporous silica nanoparticles allow the other particles to be filled with a drug through endocytosis. These emerge as highly attractive class of drug and gene delivery vectors. Gold nanoparticles
can also pack different sizes and several ligands, in order to gain function of targeting tumor cells.
Conclusion: In the present review, we compile the recent advances in mesoporous silica and gold nanoparticles as carriers of drugs and genes to tumors by passive and active approaches with descriptive examples. In addition, market status of mesoporous silica and gold based nanodrugs has been discussed. Finally, the efforts are made to discuss the current challenges and future prospectives.
Keywords: Mesoporous silica and gold based nanovectors in anticancer drug delivery, mechanisms of action, recent advances, current challenges, future prospective, tumors.
Current Organic Chemistry
Title:Recent Advances in Mesoporous Silica and Gold Based Nanovectors in Anticancer Drug Delivery System
Volume: 21 Issue: 23
Author(s): Imran Ali, Sofi Danish Mukhtar, Mohammad Nadeem Lone, Heyam Saad Ali and Hassan Y. Aboul-Enein
Affiliation:
Keywords: Mesoporous silica and gold based nanovectors in anticancer drug delivery, mechanisms of action, recent advances, current challenges, future prospective, tumors.
Abstract: Background: Advances in the medicinal nanotechnology have given upward thrust to multifunctional efficient nanocarriers that can be engineered with tunable physico-chemical traits to deliver one or extra healing agent(s) appropriately and selectively to the most cancers cells, focusing on intracellular organellespecific drug delivery.
Objective: Large pores of mesoporous silica nanoparticles allow the other particles to be filled with a drug through endocytosis. These emerge as highly attractive class of drug and gene delivery vectors. Gold nanoparticles
can also pack different sizes and several ligands, in order to gain function of targeting tumor cells.
Conclusion: In the present review, we compile the recent advances in mesoporous silica and gold nanoparticles as carriers of drugs and genes to tumors by passive and active approaches with descriptive examples. In addition, market status of mesoporous silica and gold based nanodrugs has been discussed. Finally, the efforts are made to discuss the current challenges and future prospectives.
Export Options
About this article
Cite this article as:
Ali Imran, Mukhtar Danish Sofi, Lone Nadeem Mohammad, Ali Saad Heyam and Aboul-Enein Y. Hassan , Recent Advances in Mesoporous Silica and Gold Based Nanovectors in Anticancer Drug Delivery System, Current Organic Chemistry 2017; 21 (23) . https://dx.doi.org/10.2174/1385272820666161025161853
DOI https://dx.doi.org/10.2174/1385272820666161025161853 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Advances of Heterocyclic Chemistry with Pesticide Activity
Global food safety and security will continue to be a global concern for the next 50 years and beyond. Plant diseases have had a significant impact on food safety and security throughout the entire food chain, from primary production to consumption. While conventional chemical pesticides have been traditionally used for ...read more
Calculation design of covalent/metal organic framework based catalysts
This research area combines theoretical computation and screening with machine learning for the design of covalent/metal organic framework-based catalysts, bridging the disciplines of organic chemistry, physical chemistry, computational chemistry, materials science, and machine learning. It covers several critical aspects: designing and synthesizing organic catalysts for improved performance, applying computational methods ...read more
Carbohydrates conversion in biofuels and bioproducts
Biomass pretreatment, hydrolysis, and saccharification of carbohydrates, and sugars bioconversion in biofuels and bioproducts within a biorefinery framework. Carbohydrates derived from woody biomass, agricultural wastes, algae, sewage sludge, or any other lignocellulosic feedstock are included in this issue. Simulation, techno-economic analysis, and life cycle analysis of a biorefinery process are ...read more
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Therapeutic Strategies to Target TGF-β in the Treatment of Bone Metastases
Current Pharmaceutical Biotechnology Exploiting Metabolic Differences in Glioma Therapy
Current Drug Discovery Technologies The Roles of Histone Demethylase UTX and JMJD3 (KDM6B) in Cancers: Current Progress and Future Perspectives
Current Medicinal Chemistry Scope of Lipid Nanoparticles in Neuroscience: Impact on the Treatment of Neurodegenerative Diseases
Current Pharmaceutical Design Molecular Approaches Target to Immunotherapy for HPV-Associated Cancers
Current Cancer Drug Targets Nucleic Acid Aptamers Against Protein Kinases
Current Medicinal Chemistry Passive Targeting of Cyclophosphamide-Loaded Carbonate Apatite Nanoparticles to Liver Impedes Breast Tumor Growth in a Syngeneic Model
Current Pharmaceutical Design Circulating Biomarkers for Tumor Angiogenesis: Where Are We?
Current Medicinal Chemistry Perspectives of Fullerenes, Dendrimers, and Heterocyclic Compounds Application in Tumor Treatment
Recent Patents on Nanomedicine Iron Oxide Nanoparticles Synthesized Via Green Tea Extract for Doxorubicin Delivery
Current Nanoscience CB1 Cannabinoid Receptors and their Associated Proteins
Current Medicinal Chemistry Role of Natural Phenolic Compounds in Cancer Chemoprevention via Regulation of the Cell Cycle
Current Pharmaceutical Biotechnology Dietary Manipulation of Precursor Polyunsaturated Fatty Acids Modulates Eicosanoid and Endocannabinoid Synthesis: A Potential Tool to Control Tumor Development
Current Nutrition & Food Science microRNAs as Anti-Cancer Therapy
Current Pharmaceutical Design Endocannabinoid System: A Promising Therapeutic Target for the Treatment of Haematological Malignancies?
Current Medicinal Chemistry Therapeutic Exploitation of Apoptosis and Autophagy for Glioblastoma
Anti-Cancer Agents in Medicinal Chemistry Targeting the Phosphatidylinositol 3-Kinase/AKT Pathway for the Treatment of Multiple Myeloma
Current Medicinal Chemistry Anticancer Alkylphospholipids: Mechanisms of Action, Cellular Sensitivity and Resistance, and Clinical Prospects
Current Pharmaceutical Design Small Molecule Integrin Antagonists in Cancer Therapy
Mini-Reviews in Medicinal Chemistry Glycerophospholipid Synthesis as a Novel Drug Target Against Cancer
Current Molecular Pharmacology